title: A perimenopausal woman with a small, ER/HER2-positive, node-negative breast cancer.
authors.affiliation: Department of Medicine, University of Colorado School of Medicine Aurora, Colorado 80045, USA.
authors.forename: Gabriel
authors.initials: G
authors.lastname: Brooks
authors.forename: Virginia
authors.initials: V
authors.lastname: Borges
authors.forename: Meenakshi
authors.initials: M
authors.lastname: Singh
authors.forename: Rachel
authors.initials: R
authors.lastname: Rabinovitch
authors.forename: Christina
authors.initials: C
authors.lastname: Finlayson
authors.forename: Anthony
authors.initials: A
authors.lastname: Elias
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*; D018270:Carcinoma, Ductal, Breast / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009367:Neoplasm Staging; D047648:Perimenopause; D011878:Radiotherapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis*; D011960:Receptors, Estrogen / Q000096:biosynthesis*; D021701:Sentinel Lymph Node Biopsy
chemical_list: D018931:Antineoplastic Agents, Hormonal; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen